New Jersey 2022-2023 Regular Session

New Jersey Assembly Bill A5560

Introduced
6/5/23  

Caption

Requires insurers and SHBP to provide coverage for expenses incurred in screening for ovarian cancer.

Impact

The introduction of A5560 would significantly impact state law by ensuring that ovarian cancer screenings are treated similarly to other medical conditions within health insurance plans. By providing mandated coverage, the bill aims to reduce the incidence of late-stage diagnoses among women, which could enhance their survival rates. Given that ovarian cancer is a leading cause of cancer mortality among women in the United States, the bill seeks to promote earlier detection through accessible screening, potentially changing health outcomes for many individuals across New Jersey.

Summary

Assembly Bill A5560 aims to mandate comprehensive insurance coverage for the screening of ovarian cancer for women who are either symptomatic or at risk. The bill specifically requires that insurance providers, which include hospital service corporations, medical service corporations, health maintenance organizations, and the State Health Benefits Program, offer coverage for expenses related to medically necessary screening procedures. These procedures encompass annual pelvic examinations, ultrasounds, and blood tests for cancer markers, such as CA 125. It intends to alleviate financial burdens on women who seek preventive care for this critical health issue.

Contention

While A5560 is primarily positioned as a public health initiative, it may spark debates regarding the financial implications for insurance companies and the state. Critics could argue that this mandate may lead to increased insurance premiums or strain the financial resources of insurers. Supporters, however, may contend that the long-term health benefits and potential savings on more extensive treatments for later-stage cancer justify the upfront costs of screening. The bill's passage is expected to highlight the ongoing discourse around health care accessibility and the responsibilities of insurance providers in covering necessary medical services.

Companion Bills

NJ S3801

Same As Requires insurers and SHBP to provide coverage for expenses incurred in screening for ovarian cancer.

Previously Filed As

NJ S327

Requires insurers and SHBP to provide coverage for expenses incurred in screening for ovarian cancer.

MD SB518

Health Insurance - Screening for Ovarian Cancer - Required Coverage and Prohibited Cost Sharing

NJ A4209

Requires health insurers, SHBP and SEHBP to provide coverage for diagnosis, evaluation and treatment of lymphedema.

NJ S1796

Expands requirements for health insurance carriers concerning prostate cancer screening and requires coverage be provided without cost sharing.

VA HB2097

Health insurance; coverage requirements for prostate cancer screenings.

VA SB1314

Health insurance; coverage requirements for prostate cancer screenings.

NJ A612

Requires health insurers, SHBP, and SEHBP to provide coverage for certain drug regimens for treatment of AIDS or HIV under certain circumstances.

NJ A4331

Requires health insurers, SHBP, SEHBP, and NJ FamilyCare coverage for sign language interpreter services for covered individuals who are deaf or hard of hearing.

NJ S3810

Requires health insurers to provide coverage for certain imaging related to breast cancer detection.

NJ S2267

Requires health insurers, SHBP, SEHBP, and NJ FamilyCare coverage for sign language interpreter services for covered individuals who are deaf or hard of hearing.

Similar Bills

No similar bills found.